Which has the lower trailing P/E, AZN or HUM?

AZN has the lower trailing P/E: AZN trades at 12.77 and HUM at 40.76. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or HUM?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus HUM at 11.71%.

Does AZN or HUM pay a bigger dividend?

AZN yields 1.89% and HUM yields 0.70% based on trailing dividends and the latest price.

Is AZN or HUM more profitable?

AZN runs the higher net margin — AZN at 17.19% versus HUM at 0.82%.

How have AZN and HUM total returns compared?

Over the past 10 years, AZN delivered 13.96% and HUM delivered 9.18% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Humana Inc. (HUM)

A side-by-side comparison of AstraZeneca PLC and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$133.67B

$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT

HUM

Humana Inc.

$46.67B

$388.71HealthcareDelayed quote: Jul 28, 2026, 4:01 PM EDT

Total return — AZN vs HUM

growth of $100 · dividends reinvested · last 30y

AZN +2029.9%HUM +2547.6%HUM compounded faster

AZN HUM

AZN vs HUM: by the numbers

•AZN is the larger company ($133.67B vs $46.67B market cap).
•AZN trades at the lower trailing earnings multiple (12.77 vs 40.76 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.19% vs 0.82% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 11.71% CAGR).
•AZN pays the higher dividend yield (1.89% vs 0.70%).

Metrics side by side

Valuation

Metric	AZN	HUM
P/E ratio	12.77	40.76
Forward P/E	16.58	42.42
P/S ratio	2.19	0.34
P/B ratio	2.80	2.48
PEG ratio	0.29	N/A
EV / EBITDA	7.89	25.16
FCF yield	6.09%	2.77%

Profitability

Metric	AZN	HUM
Gross margin	81.68%	14.01%
Operating margin	23.69%	1.01%
Net margin	17.19%	0.82%
ROE	21.95%	6.08%
ROIC	13.03%	3.12%

Dividends

Metric	AZN	HUM
Dividend yield	1.89%	0.70%
Payout ratio	24.24%	26.90%

Growth (annualized)

Metric	AZN	HUM
Revenue CAGR (5Y)	16.99%	11.71%
EPS CAGR (5Y)	22.02%	-17.27%
FCF CAGR (5Y)	15.68%	-17.19%
Total return CAGR (5Y)	10.56%	-1.91%

Frequently asked

Which has the lower trailing P/E, AZN or HUM?: AZN has the lower trailing P/E: AZN trades at 12.77 and HUM at 40.76. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or HUM?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus HUM at 11.71%.
Does AZN or HUM pay a bigger dividend?: AZN yields 1.89% and HUM yields 0.70% based on trailing dividends and the latest price.
Is AZN or HUM more profitable?: AZN runs the higher net margin — AZN at 17.19% versus HUM at 0.82%.
How have AZN and HUM total returns compared?: Over the past 10 years, AZN delivered 13.96% and HUM delivered 9.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Humana P/E ratio AstraZeneca dividend yield Humana dividend yield AstraZeneca ROE Humana ROE AstraZeneca operating margin Humana operating margin AstraZeneca revenue growth Humana revenue growth AstraZeneca free cash flow Humana free cash flow

AstraZeneca & Humana appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.